FIGURE 1.
Chemical structures of the COT inhibitors (E)-3-(2-amino-5-(naphthalen-2-yl)pyridin-3-yl)acrylic acid (compound 1), 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine (compound 2) 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione (compound 3).